Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Icad Inc (ICAD)

Icad Inc (ICAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
The Next Wave of Health AI: Analysts Highlight Breakthroughs in Clinical Trials and Patient Care

USA News Group  Commentary Issued on behalf of Avant Technologies Inc.   Vancouver, BC – December 17, 2024  – USA News Group News Commentary – Artificial intelligence (AI) is on the brink of becoming...

HWAIF : 1.4070 (+0.50%)
AIDX.TO : 2.05 (+2.50%)
AVAI : 0.5025 (+3.50%)
BTAI : 0.5732 (+38.45%)
RDNT : 72.75 (+1.73%)
ICAD : 2.02 (-1.94%)
iCAD, Inc. Announces Presentation of Four Novel AI-Driven Breast Cancer Research Abstracts at 2024 San Antonio Breast Cancer Symposium

iCAD announced acceptance of four AI-driven breast cancer abstracts for presentation at the 2024 SABCS, focusing on detection and risk assessment.Quiver AI SummaryiCAD, Inc., a leader in AI-powered cancer...

ICAD : 2.02 (-1.94%)
SABCS 2024: New Research Assesses iCAD’s Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations

ICAD : 2.02 (-1.94%)
iCAD, Inc. Partners with Cascaid Health to Launch ProFound Health at RSNA 2024, Expanding Access to AI-Driven Breast Health Solutions

iCAD announces collaboration with Cascaid Health to enhance access to AI-driven breast health solutions at RSNA 2024.Quiver AI SummaryiCAD, Inc. announced that it will showcase its advanced breast health...

ICAD : 2.02 (-1.94%)
CORRECTION – iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024

ICAD : 2.02 (-1.94%)
iCAD, Inc. Showcases AI-Powered Breast Health Innovations and Partnership with Cascaid Health at RSNA 2024

iCAD will present AI-driven breast health solutions at RSNA 2024, showcasing new technology and partnerships to improve cancer detection.Quiver AI SummaryiCAD, Inc., a leading provider of AI-powered cancer...

ICAD : 2.02 (-1.94%)
iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024

ICAD : 2.02 (-1.94%)
Icad: Q3 Earnings Snapshot

Icad: Q3 Earnings Snapshot

ICAD : 2.02 (-1.94%)
iCAD Reports Financial Results for Third Quarter Ended September 30, 2024

ICAD : 2.02 (-1.94%)
iCAD's ProFound Detection Version 4.0 Gains FDA Clearance

ICAD : 2.02 (-1.94%)

Barchart Exclusives

2 Natural Gas Stocks to Buy as Cold Weather Creeps Up
While extreme cold is anticipated to push natural gas demand and prices higher, these two dividend-paying natural gas stocks could be wise investments now. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar